Various doses of fractioned irradiation modulates multidrug resistance 1 expression differently through hypoxia-inducible factor 1α in esophageal cancer cells

Diseases of the Esophagus

Volumn 24, Issue 7, 2011, Pages 481-488

  Zhang, G J ^a   Gao, R ^a   Wang, J S ^a   Fu, J K ^a   Zhang, M X ^a   Jin, X ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Esophageal cancer; HIF1 ; MDR1; Radiation; SiRNA

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; SMALL INTERFERING RNA;

ARTICLE; CANCER CELL; CANCER RADIOTHERAPY; CELL SURVIVAL; CONTROLLED STUDY; ESOPHAGUS CANCER; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE FRACTIONATION; TUMOR BIOPSY; WESTERN BLOTTING;

CELL LINE, TUMOR; DOSE FRACTIONATION; ESOPHAGEAL NEOPLASMS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; P-GLYCOPROTEIN;

EID: 80053049211     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2010.01168.x     Document Type: Article

References (41)

1. Daly J M, Karnell L H, Menck H R. National Cancer Data Base report on esophageal carcinoma. Cancer Res 1996; 78: 1820-8.
2. Sagar P M, Gauperaa T, Sue-Ling H, McMahon M J, Johnston D. An audit of the treatment of cancer of the oesophagus. Gut 1994; 35: 941-5.
3. Urschel J D, Ashiku S, Thurer R, Sellke F W. Salvage or planned esophagectomy after chemoradiation therapy for locally advanced esophageal cancer - a review. Dis Esophagus 2003; 16: 60-5.
4. Kaklamanos I G, Walker G R, Ferry K, Franceschi D, Livingstone A S. Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials. Ann Surg Oncol 2003; 10: 754-61.
5. Urschel J D, Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2003; 185: 538-43.
6. Chan C W A, Griffith J, Leung S etal. Prediction of tumor responses towards chemotherapy in squamous esophageal cancer patients by quantitative assesssment of MDR, MRP, GST-pi and DNA topoisomerase II gene expressions using endoscopic biopsy tissue samples. Gastroenterology 1999; 116: G1691.
7. Zampierl L, Veale R B. P-glycoprotein expression in human oesophageal squamous carcinoma cell lines. S Afr J Sci 2001; 97: 329-33.
8. Wang G L, Jiang B, Rue E A. Hypoxia-inducible factor 1 is a basic helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A 1995; 92: 5510-14.
9. Unruh A R A, Mohamed H G, Johnson R S etal. The hypoxia-inducible factor-1α is a negative factor for tumor therapy. Oncogene 2003; 22: 3213-20.
10. Koukourakis M I, Giatromanolaki A, Skarlatos J etal. Hypoxia inducible factor (HIF-1 α and HIF-2α) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy. Cancer Res 2001; 61: 1830-2.
11. Comerford K M, Wallace T J, Karhausen J, Louis N A, Montalto M C, Colgan S P. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res 2002; 62: 3387-94.
12. Huang L, Zhang Q H, Ao Q L, Xing H, Lu Y P, Ma D. Effect of hypoxia on the chemotherapeutic sensitivity of human ovarian cancer cells to paclitaxel and its mechanism. Zhonghua Zhong Liu Za Zhi 2007; 29: 96-100.
13. Liu L, Ning X, Sun L etal. Hypoxia-inducible factor-1 alpha contributes to hypoxia-induced chemoresistance in gastric cancer. Cancer Sci 2008; 99: 121-8.
14. Xia S, Yu S, Yuan X. Effects of hypoxia on expression of P-gp and multidrug resistance protein in human lung adenocarcinoma A549 cell line. J Huazhong Univ Sci Technolog Med Sci 2005; 25: 279-81.
15. Erler J T, Cawthorne C J, Williams K J etal. Hypoxia-mediated down-regulation of bid and bax in tumors occurs via hypoxia-inducible factor 1-dependent and -independent mechanisms and contributes to drug resistance. Mol Cell Biol 2004; 24: 2875-99.
16. Zhu H, Chen X P, Luo S F, Guan J, Zhang W G, Zhang B X. Involvement of hypoxia-inducible factor-1-alpha in multidrug resistance induced by hypoxia in HepG2 cells. J Exp Clin Cancer Res 2005; 24: 565-74.
17. Song X, Liu X, Chi W etal. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene. Cancer Chemother Pharmacol 2006; 58: 776-84.
18. Ljungkvist A S E, Bussink J, Kaanders J, Wiedenmann N E, Vlasman R, van der Kogel A J. Dynamics of hypoxia, proliferation and apoptosis after irradiation in a murine tumor model. Radiat Res 2006; 165: 326-36.
19. Dunst J, Hansgen G, Lautenschlager C, Fuchsel G, Becker A. Oxygenation of cervical cancers during radiotherapy and radiotherapy + cis-retinoic acid/interferon - a new noninvasive predictive assay. Int J Radiat Oncol Biol Phys 1999; 43: 367-73.
20. Bussink J, Kaanders J, Rijken P, Raleigh J A, Van der Kogel A J. Changes in blood perfusion and hypoxia after irradiation of a human squamous cell carcinoma xenograft tumor line. Radiat Res 2000; 153: 398-404.
21. Stadler P, Feldmann H J, Creighton C, Kau R, Molls M. Changes in tumor oxygenation during combined treatment with split-course radiotherapy and chemotherapy in patients with head and neck cancer. Radiother Oncol 1998; 48: 157-64.
22. Hill B T, Moran E, Etievant D etal. Low-dose twice-daily fractionated X-irradiation of ovarian tumor cells in vitro generates drug-resistant cells overexpressing two multidrug resistance-associated proteins, P-glycoprotein and MRP. Anticancer Drugs 2000; 11: 193-200.
23. Ng I O, Lam K Y, Ng M, Kwong D L, Sham J S. Expression of P-glycoprotein, a multidrug resistance gene product, is induced by radiotherapy in patients with oral squamous cell carcinoma. Cancer 1998; 83: 851-7.
24. Ana M, Sanchez J T B, Patricia V S. Fractionated ionizing radiation accelerates loss of amplified MDRl genes harbored by extrachromosomal DNA in tumor cells. Cancer Res 1998; 58: 3845-54.
25. Campling B G, Haworth A C, Baker H M etal. Establishment and characterization of a panel of human lung cancer cell lines. Cancer 1992; 69: 2064-74.
26. Nieth C, Priebsch A, Stege A, Lage H. Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference (RNAi). FEBS Lett 2003; 545: 144-50.
27. Simiantonaki N, Taxeidis M, Jayasinghe C, Kurzik-Dumke U, Kirkpatrick C J. Hypoxia-inducible factor I alpha expression increases during colorectal carcinogenesis and tumor progression. BMC Cancer 2008; 8: 320.
28. Yamamoto Y, Ibusuki M, Okumura Y etal. Hypoxia-inducible factor 1 alpha is closely linked to an aggressive phenotype in breast cancer. Breast Cancer Res Treat 2008; 110: 465-75.
29. Chai C Y, Chen W T, Hung W C etal. Hypoxia-inducible factor-1 alpha expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma. J Clin Pathol 2008; 61: 658-64.
30. Milroy R, Plumb J A, Batstone P etal. Lack of expression of P-glycoprotein in 7 small cell lung cancer cell lines established both from untreated and from treated patients. Anticancer Res 1992; 12: 193-200.
31. Noonan K E, Beck C, Holzmayer T A etal. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci U S A 1990; 87: 7160-4.
32. Goldstein L J, Galski H, Fojo A etal. Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 1989; 81: 116-24.
33. Wouters A, Pauwels B, Filip L, Vermorken J B. Review: implications of in vitro research on the effect of radiotherapy and chemotherapy under hypoxic conditions. Oncologist 2007; 12: 690-712.
34. Nardinocchi L, Puca R, Sacchi A, D'Orazi G. Inhibition of HIF-Ialpha activity by homeodomain-interacting protein kinase-2 correlates with sensitization of chemoresistant cells to undergo apoptosis. Mol Cancer 2009; 8: 1.
35. Wu X A, Sun Y, Fan Q X, Wang L X, Wang R L, Zhang L. Impact of RNA interference targeting hypoxia-inducible factor-1alpha on chemosensitivity in esophageal squamous cell carcinoma cells under hypoxia. Zhonghua Yi Xue Za Zhi 2007; 87: 2640-4.
36. Cosse J P, Michiels C. Tumour hypoxia affects the responsiveness of cancer cells to chemotherapy and promotes cancer progression. Anticancer Agents Med Chem 2008; 8: 790-7.
37. Lelong-Rebel I, Brisson C, Fabre M, Bergerat J P, Rebel G. Effect of pO(2) on antitumor drug cytotoxicity on MDR and non-MDR variants selected from the LoVo metastatic colon carcinoma cell line. Anticancer Res 2008; 28: 55-68.
38. He G P, Zhang S Z, Wang Y C etal. Time and dose effect of RNA interference mediated by short hairpin RNA. Prog Biochem Biophysics 2005; 32: 258-67.
39. Kobayashi N, Matsui Y, Kawase A etal. Vector-based in vivo RNA interference: dose- and time dependent suppression of transgene expression. J Pharmacol Exp Ther 2004; 308: 688-93.
40. Rofstad E K, Mathiesen B, Galappathi K. Increased metastatic dissemination in human melanoma xenografts after subcurative radiation treatment: radiation-induced increase in fraction of hypoxic cells and hypoxia-induced up-regulation of urokinase-type plasminogen activator receptor. Cancer Res 2004; 64: 13-18.
41. Kitakabu Y, Shibamoto Y, Sasai K, Ono K, Abe M. Variations of the hypoxic fraction in the Scc-Vii tumors after single dose and during fractionated radiation-therapy - assessment without anesthesia or physical restraint of mice. Int J Radiat Oncol Biol Phys 1991; 20: 709-14.